Divi’s Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 101474.04 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated sales of Rs 1701.44 Crore, down 2.74 % from last quarter Sales of Rs 1749.30 Crore and up 21.86 % from last year same quarter Sales of Rs 1396.26 Crore Company reported net profit after tax of Rs 470.62 Crore in latest quarter.
Investment Rationale
Stock has moved above its 50 DMA and has been forming higher highs on daily scale
Promoter/FII Holdings
Promoters held 52 per cent stake in the company as of June 30, 2020, while FIIs held 18.2 per cent, DIIs 15.6 per cent and public and others 14.2 per cent.